Customized research for RLMD vs. INO!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for RLMD vs. INO.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Relmada Therapeutics, Inc. vs. Inovio Pharmaceuticals, Inc.

Industry Match! Industry of Both RLMD and INO:

Health Care/Life Sciences

RLMD
Data Last Updated: More than 2 wks ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 735.436M


P/E: N/A

P/S: N/A

Q P/B: 6.5

Y Rev: -

Q Rev: -

Beta: 0.64

RLMD Share Stats

Outstanding Shares

15.20M

Float Shares

13.76M

Percent of Float Short

13.18%

RLMD Insider Stats

Percent Outstanding Insider Ownership

6.17%

Percent Outstanding Institution Ownership

5.34%

RLMD Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RLMD in Pulse Portal

Stream of Posts

RLMD Symbol Page

Share RLMD Insights

Express Sentiment

'Buy' or 'Sell' RLMD

RLMD Profile

CEO

Dr. Sergio Traversa

Exchange

Nasdaq

Employees

4.00

About

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and...

RLMD Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(17.32M)

Cash Flow Statement

Change in Cash / Investments

6.98M

Balance Sheet

Cash / Investments

9.22M

Short Term Debt

364,204

Long Term Debt

None

Total Current Assets

9.98M

Total Current Liabilities

2.61M

Total Assets

10.22M

Total Liabilities

2.61M

Stockholder Equity

7.61M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(10.67M)

Cash Flow Statement

Q Change in Cash / Investments

(24.05M)

Balance Sheet

Q Cash / Investments

114.92M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

115.25M

Q Total Current Liabilities

2.26M

Q Total Assets

115.42M

Q Total Liabilities

2.26M

Q Stockholder Equity

113.16M

RLMD Charts

10-Year Chart

RLMD 10-Year Chart

5-Year Chart

RLMD 5-Year Chart

1-Year Chart

RLMD 1-Year Chart

6-Month Chart

RLMD 6-Month Chart

3-Month Chart

RLMD 3-Month Chart

1-Month Chart

RLMD 1-Month Chart

1-Day Chart

RLMD 1-Day Chart

INO
Data Last Updated: More than a wk ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 5.01B


P/E: N/A

P/S: 1218.98

Q P/B: 27.18

Y Rev: 4.11M

Q Rev: 1.33M

Beta: 1.39

INO Share Stats

Outstanding Shares

158.10M

Float Shares

154.14M

Percent of Float Short

16.72%

INO Insider Stats

Percent Outstanding Insider Ownership

3.4%

Percent Outstanding Institution Ownership

36.47%

INO Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

+2

More Social Data

INO in Pulse Portal

Stream of Posts

INO Symbol Page

Share INO Insights

Express Sentiment

'Buy' or 'Sell' INO

INO Profile

CEO

Dr. J. Joseph Kim

Exchange

Nasdaq

Employees

194.00

About

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system's...

INO Financials

Annual Financials

Income Statement

Revenue

4.11M

Net Income

(120.55M)

Cash Flow Statement

Change in Cash / Investments

(1.5M)

Balance Sheet

Cash / Investments

89.53M

Short Term Debt

2.07M

Long Term Debt

77.02M

Total Current Assets

94.2M

Total Current Liabilities

31.99M

Total Assets

152.02M

Total Liabilities

146.48M

Stockholder Equity

3.44M

Quarterly Financials

Income Statement

Q Revenue

1.33M

Q Net Income

(33.14M)

Cash Flow Statement

Q Change in Cash / Investments

136.25M

Balance Sheet

Q Cash / Investments

270M

Q Short Term Debt

2.13M

Q Long Term Debt

76.56M

Q Total Current Assets

275.54M

Q Total Current Liabilities

32.29M

Q Total Assets

338.92M

Q Total Liabilities

151.07M

Q Stockholder Equity

184.32M

INO Charts

10-Year Chart

INO 10-Year Chart

5-Year Chart

INO 5-Year Chart

1-Year Chart

INO 1-Year Chart

6-Month Chart

INO 6-Month Chart

3-Month Chart

INO 3-Month Chart

1-Month Chart

INO 1-Month Chart

1-Day Chart

INO 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon